Search filters

List of works by Inge Vliegen

ChemInform Abstract: Selective Inhibitors of Picornavirus Replication

Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase Inhibitors

scientific article (publication date: September 2008)

Comparative Study of the Genetic Barrier and Pathways Towards Resistance of Selective Inhibitors of HCV Replication

scientific article published in 2009

Comparative study of the genetic barriers and pathways towards resistance of selective inhibitors of hepatitis C virus replication

scientific article

Coumarins hinged directly on benzimidazoles and their ribofuranosides to inhibit hepatitis C virus

scientific article

Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation

scientific article published on 01 January 2004

DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A

scientific article (publication date: 27 October 2010)

Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors

scientific article

Deletion of the vaccinia virus F13L gene results in a highly attenuated virus that mounts a protective immune response against subsequent vaccinia virus challenge

scientific article published on November 25, 2011

Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin

scientific article published on 13 July 2006

Hepatitis C virus-specific directly acting antiviral drugs

scientific article published on January 2013

Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease?

scientific article

Improved detection and quantification of mouse cytomegalovirus by real-time PCR

scientific article published on December 1, 2003

In Vitro Selection and Characterization of Hepatitis C Virus Replicons Double or Triple Resistant to Various Non-nucleoside HCV Polymerase Inhibitors

scientific article published in 2010

In vitro Anti-hepatitis C Virus (HCV) Activities and Resistance Profile of Debio 025, A Non-immunosuppressive Cyclophilin Binding Molecule

scientific article published in 2009

In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance

scientific article published on 30 May 2015

In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitors

scientific article published on 20 May 2011

MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice

scientific article published in August 2002

Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymerase

scientific article

Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice

scientific article published on 01 July 2005

Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis

scientific article published on 01 October 2004

Rapid identification of bacteria by real-time amplification and sequencing of the 16S rRNA gene

scientific article

Rational design of antiviral drug combinations based on equipotency using HCV subgenomic replicon as an in vitro model.

scientific article published on 14 November 2017

Selecting and characterizing drug-resistant hepatitis C virus replicon

scientific article published on January 2013

Selective inhibitors of picornavirus replication

scientific article

Statins potentiate the in vitro anti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development

scientific article published on July 2009

Substituted imidazopyridines as potent inhibitors of HCV replication

scientific article published on 26 February 2009

Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents

scientific article published on 8 October 2007